| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Tata Nifty MidSmall Healthcare Index Fund Reg (G) |
| [Equity: Index] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
-1.48 |
| Equity |
101.41 |
| Trep |
0.07 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
39.91% |
| Top 10 Holdings |
63.24% |
| Top 25 Holdings |
95.64% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
76.33 |
| Healthcare |
25.08 |
| Cash |
-1.41 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
5.11 |
| PE Ratio |
40.51 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Lupin Limited |
10.41 |
| Fortis Health Care Ltd |
9.17 |
| Laurus Labs Limited |
7.80 |
| Aurobindo Pharma Limited |
6.37 |
| Alkem Laboratories Limited |
6.16 |
| Glenmark Pharmaceuticals Limited |
6.00 |
| Biocon Limited |
5.19 |
| Mankind Pharma Limited |
4.74 |
| IPCA Laboratories Limited |
3.97 |
| Krishna Inst of Medical Sciences Ltd. |
3.43 |
| J B Chemicals and Pharma Ltd |
3.13 |
| Aster DM Healthcare Limited |
2.84 |
| Gland Pharma Limited |
2.71 |
| Abbott India Limited |
2.58 |
| AFebta Pharma Limited |
2.35 |
| Narayana Hrudalaya Ltd |
2.32 |
| Wockhardt Limited |
2.10 |
| Neuland Laboratories Limited |
2.05 |
| Dr Lal Path Labs Ltd |
2.02 |
| Glaxosmithkline Pharma Ltd |
1.98 |
| EQ- GLOBAL HEALTH LTD. |
1.80 |
| Piramal Pharma Limited |
1.80 |
| Natco Pharma Limited |
1.65 |
| Granules India Limited |
1.58 |
| Syngene International Limited |
1.49 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|